Pterostilbene-Loaded Polydopamine Nanoparticles Down-Regulate Tumor Necrosis Factor-α and Improve Myocardial Function in Mice with Acute Myocardial Infarction

Abstract

TNF-α expression is related to myocardial function damage and recovery in patients with acute myocardial infarction, but its mechanism is not clear. 50 SD mice, 10 in each group, were in this study divided into TNF-α group, Notch1/eIF3a agonist group, model group, positive control group, and control group. The cardiac function score, myocardial infarction volume, myocardial cell apoptosis index, TNF-α expression, and Notch1/eIF3a pathway factor expression were observed. The size of polydopamine nanoparticles carrying pterostilbene was about 15.5 nm, and cardiac function score, myocardial infarction volume, myocardial cell apoptosis index, and myocardial cell apoptosis number in the model group and Notch1/eIF3a agonist group were higher than model group and Notch1/eIF3a agonist group (P < 0.05). Compared with model group, the Notch1/eIF3a agonist group, TNF-α group, and positive control group showed no differences (P > 0.05). The model group and Notch1/eIF3a agonist group had highest inflammatory response and lowest oxidative stress, which were significantly different from other groups (P < 0.05). The expression of TNF-α in Notch1/eIF3a agonist group, model group, and positive control group all decreased, which was significantly different from other groups (P < 0.05). The expressions of p-IL-6 and p-eIF3a in model group, Notch1/eIF3a agonist group and positive control group were all highest (P < 0.05). Carrying Pterostilbene-loaded polydopamine nanoparticles (PPNs) therefore inhibits apoptosis of cardiomyocytes, Notch1/eIF3a signaling pathway and inflammatory response and oxidative stress of myocardial system, and protects cardiomyocytes of model mice.